More articles from Brain Imaging Council Young Investigator Award Symposium

You have access
Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT_1A receptor biased agonists.
Benjamin Vidal, Sylvain Fieux, Marjorie Villien, Didier Le Bars, Adrian Newman-Tancredi, Nicolas Costes and Luc Zimmer

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 11;
You have access
Potential effect of a fluorine position in the aromatic molecule (CP-118,954) on the neuropharmacological property and PET imaging quantification for AChE expression
Dodam Park, Byung Seok Moon, Hyun Soo Park, JaeHo Jung, Byung Chul Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 8;
You have access
Optimization of S1P1-specific PET radioligands for imaging neuroinflammation
Hui Liu, Junbin Han, Hongjun Jin, Zonghua Luo, Adam Rosenberg, Xuyi Yue, Joel Perlmutter and Zhude Tu

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 10;
You have access
Evaluation of default mode network by quantitative ¹⁵O-labeled gases and water PET: comparison study between cerebral blood flow and oxygen consumption.
JO AOE, Tadashi Watabe, Eku Shimosegawa, Hiroki Kato, Yasukazu Kanai, Sadahiro Naka, KEIKO MATSUNAGA, Kayako Isohashi, Mitsuaki Tatsumi and Jun Hatazawa

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 12;
You have access
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects
Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart De Laat, Guy Bormans, Hendrik Peuskens and Koen Van Laere

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 14;
You have access
18F-FDG PET brain in presurgical management of patients with periventricular nodular heterotopias related epilepsy: diagnostic features and long term outcome
Cristina Popescu, Claudio Rossetti, Roberto Mai, Roberto Sara, Massimo Milella, Daniela Redaelli, Aurora Liuni and Federico Caobelli

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 9;
You have access
Assessment of potential protective effect on dopaminergic neuron by an Fas-associated factor 1 inhibitor treatment using [¹⁸F]FE-PE2I PET in a Parkinson’s disease mouse model
Hyun Soo Park, Byung Seok Moon, Sung-Eun Yoo, Jae Moon Lee, Yeon-Tae Chung, Eunhee Kim, Byung Chul Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 13;
You have access
Evaluation of the associations between [11C]PIB and [18F]AV1451 PET retention and MRI atrophy in Alzheimer’s Disease
Leonardo Iaccarino, Gautam Tammewar, Daniel Schonhaut, Samuel Lockhart, Rik Ossenkoppele, James O'Neil, Mustafa Janabi, Suzanne Baker, Nagehan Ayakta, Andreas Lazaris, Maria Luisa Gorno-Tempini, Bruce Miller, William Jagust and Gil Rabinovici

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 18;
You have access
Direct Comparison of [18F]FC119S and [11C]PiB of PET in Alzheimer's Disease, Mild Cognitive Impairment and Healthy Control Groups; an Open-label, Single-dose, Parallel, Evaluator-blind, Investigator Clinical Trial
Joon Yeun Park, Byung Hyun Byun, Sang Moo Lim, Ilhan Lim, Jihyun Park, Hansol Moon, Joon Ho Choi, Kyeong Min Kim, Kyo Chul Lee, Su-Yeon Park, Jeong-Ho Ha, Jun-Young Lee and Byung Il Kim

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 19;
You have access
Concurrently upregulated and downregulated D2/D3 receptor systems in cocaine use disorder using [11C]PHNO
Patrick Worhunsky, David Matuskey, Jean-Dominique Gallezot, Edward Gaiser, Nabeel Nabulsi, Gustavo Angarita, Vince Calhoun, Robert Malison, Marc Potenza and Richard Carson

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 16;

Main menu

User menu

Search

More articles from Brain Imaging Council Young Investigator Award Symposium

Pages